Trademark: 85855235
Word
CAMRESE LO
Status
Registered
Status Code
800
Status Date
Tuesday, March 19, 2024
Serial Number
85855235
Registration Number
4417937
Registration Date
Tuesday, October 15, 2013
Mark Type
4000
Filing Date
Wednesday, February 20, 2013
Published for Opposition
Tuesday, July 30, 2013

Trademark Owner History
Teva Pharmaceuticals USA, Inc. - Original Registrant

Classifications
5 Pharmaceuticals, namely, oral contraceptives, hormone replacement therapies and hormonal agents for treating disorders and conditions related to women's health
"LO"

Trademark Events
Mar 19, 2024
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Mar 19, 2024
Registered And Renewed (First Renewal - 10 Yrs)
Mar 19, 2024
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Mar 19, 2024
Case Assigned To Post Registration Paralegal
Oct 16, 2023
Teas Section 8 & 9 Received
Oct 15, 2022
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jan 28, 2020
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Jan 28, 2020
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Jan 7, 2020
Teas Response To Office Action-Post Reg Received
Nov 22, 2019
Post Registration Action Mailed - Sec. 8 & 15
Nov 22, 2019
Case Assigned To Post Registration Paralegal
Oct 16, 2019
Teas Change Of Correspondence Received
Oct 16, 2019
Teas Section 8 & 15 Received
Oct 15, 2018
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 15, 2013
Registered-Principal Register
Jul 30, 2013
Official Gazette Publication Confirmation E-Mailed
Jul 30, 2013
Published For Opposition
Jul 10, 2013
Notification Of Notice Of Publication E-Mailed
Jun 25, 2013
Law Office Publication Review Completed
Jun 25, 2013
Assigned To Lie
Jun 7, 2013
Approved For Pub - Principal Register
Jun 7, 2013
Examiner's Amendment Entered
Jun 7, 2013
Notification Of Examiners Amendment E-Mailed
Jun 7, 2013
Examiners Amendment E-Mailed
Jun 7, 2013
Examiners Amendment -Written
Jun 4, 2013
Assigned To Examiner
Feb 27, 2013
New Application Office Supplied Data Entered
Feb 24, 2013
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24